ATE211651T1 - Benzopyranphenolderivate zur anwendung als bakterienhemmende, antivirale und wundheilende mittel - Google Patents

Benzopyranphenolderivate zur anwendung als bakterienhemmende, antivirale und wundheilende mittel

Info

Publication number
ATE211651T1
ATE211651T1 AT95116380T AT95116380T ATE211651T1 AT E211651 T1 ATE211651 T1 AT E211651T1 AT 95116380 T AT95116380 T AT 95116380T AT 95116380 T AT95116380 T AT 95116380T AT E211651 T1 ATE211651 T1 AT E211651T1
Authority
AT
Austria
Prior art keywords
antiviral
wound healing
benzopyranphenol
bacterial
derivatives
Prior art date
Application number
AT95116380T
Other languages
English (en)
Inventor
Maria Marconius
Original Assignee
Fockerman Jasmine
Fockerman Michel
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fockerman Jasmine, Fockerman Michel filed Critical Fockerman Jasmine
Application granted granted Critical
Publication of ATE211651T1 publication Critical patent/ATE211651T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C07D311/22—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4
    • C07D311/26—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4 with aromatic rings attached in position 2 or 3
    • C07D311/28—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4 with aromatic rings attached in position 2 or 3 with aromatic rings attached in position 2 only
    • C07D311/32—2,3-Dihydro derivatives, e.g. flavanones
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Virology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pyrane Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
AT95116380T 1991-02-15 1992-02-14 Benzopyranphenolderivate zur anwendung als bakterienhemmende, antivirale und wundheilende mittel ATE211651T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US65680191A 1991-02-15 1991-02-15
US07/809,420 US5449794A (en) 1991-02-15 1991-12-17 Benzopyran phenol derivatives for use as antibacterial agents

Publications (1)

Publication Number Publication Date
ATE211651T1 true ATE211651T1 (de) 2002-01-15

Family

ID=27097268

Family Applications (2)

Application Number Title Priority Date Filing Date
AT95116380T ATE211651T1 (de) 1991-02-15 1992-02-14 Benzopyranphenolderivate zur anwendung als bakterienhemmende, antivirale und wundheilende mittel
AT92905459T ATE148341T1 (de) 1991-02-15 1992-02-14 Benzopyranphenolderivate zur verwendung als immunstimulierende mittel

Family Applications After (1)

Application Number Title Priority Date Filing Date
AT92905459T ATE148341T1 (de) 1991-02-15 1992-02-14 Benzopyranphenolderivate zur verwendung als immunstimulierende mittel

Country Status (11)

Country Link
US (1) US5449794A (de)
EP (2) EP0707851B1 (de)
JP (1) JP3682721B2 (de)
AT (2) ATE211651T1 (de)
AU (1) AU668348B2 (de)
CA (1) CA2104114C (de)
DE (2) DE69217206T2 (de)
DK (2) DK0707851T3 (de)
ES (2) ES2100335T3 (de)
NZ (1) NZ241633A (de)
WO (1) WO1992014458A1 (de)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5861430A (en) * 1991-12-17 1999-01-19 Jasmine Fockerman Benzopyran phenol derivates for use as antibacterial, antiviral or immunostimulating agents
US8039026B1 (en) 1997-07-28 2011-10-18 Johnson & Johnson Consumer Companies, Inc Methods for treating skin pigmentation
DE19740879A1 (de) * 1997-09-17 1999-04-01 Beiersdorf Ag Desodorierende Zubereitungen auf der Basis von Flavonderivaten und/oder Flavanonderivaten, insbesondere von Flavonoiden
AU2904899A (en) * 1998-03-16 1999-10-11 Procter & Gamble Company, The Compositions for regulating skin appearance
DE19813802A1 (de) * 1998-03-27 1999-11-11 Retro Tech Gmbh Anti-virale Wirkung von Propolis durch Inhibition viraler Nukleinsäure Polymerasen
US6750229B2 (en) 1998-07-06 2004-06-15 Johnson & Johnson Consumer Companies, Inc. Methods for treating skin pigmentation
US8106094B2 (en) 1998-07-06 2012-01-31 Johnson & Johnson Consumer Companies, Inc. Compositions and methods for treating skin conditions
US8093293B2 (en) 1998-07-06 2012-01-10 Johnson & Johnson Consumer Companies, Inc. Methods for treating skin conditions
US6555523B1 (en) 1999-07-08 2003-04-29 Patrick T. Prendergast Use of cirsiliol and derivatives to treat infections
US7985404B1 (en) 1999-07-27 2011-07-26 Johnson & Johnson Consumer Companies, Inc. Reducing hair growth, hair follicle and hair shaft size and hair pigmentation
US7309688B2 (en) 2000-10-27 2007-12-18 Johnson & Johnson Consumer Companies Topical anti-cancer compositions and methods of use thereof
US8431550B2 (en) 2000-10-27 2013-04-30 Johnson & Johnson Consumer Companies, Inc. Topical anti-cancer compositions and methods of use thereof
BR0006272A (pt) * 2000-12-22 2002-08-13 Maria Cristina Marcucc Ribeiro Processo de identificação de tipagens da própolis brasileira
US6555143B2 (en) 2001-02-28 2003-04-29 Johnson & Johnson Consumer Products, Inc. Legume products
US7192615B2 (en) 2001-02-28 2007-03-20 J&J Consumer Companies, Inc. Compositions containing legume products
RU2185181C1 (ru) * 2001-03-05 2002-07-20 ООО "Тенториум" Способ получения водного экстракта прополиса эй-пи-ви
HU225388B1 (en) * 2001-05-31 2006-11-28 Viola Dr Szabo Rubber device for preventing infections and reducing spread of infections
US6803056B2 (en) * 2001-09-14 2004-10-12 Terence M. Dolak Method and composition for treating viral outbreaks
DE20306600U1 (de) * 2003-04-29 2003-09-04 Karpfl, Peter, 47546 Kalkar Hautpflegeprodukt bzw. Wundpflegemittel
EP2862600B1 (de) * 2011-12-20 2020-02-12 Oriflame Research and Development Ltd. Verbindungen mit Anti-Aging-Wirkung
WO2017075715A1 (en) * 2015-11-05 2017-05-11 Universite Laval Compositions favoring wound repair
EP4031128A4 (de) * 2019-09-16 2023-12-13 Koda Therapeutics, LLC Antimikrobielle verbindungen und zusammensetzungen sowie verwendungen davon

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1057349B (de) * 1955-12-31 1959-05-14 Emi Ltd Schallplatte mit herausnehmbarem und wiedereinsetzbarem Mittelteil und Verfahren zu ihrer Herstellung
AT320869B (de) * 1972-12-08 1975-03-10 Trommsdorff Fa H Verfahren zur Herstellung eines neuen Flavanonderivates
NZ193316A (en) * 1979-04-10 1984-07-31 Hoffmann La Roche 3-alkoxyflavone derivatives and pharmaceutical compositions
US4238483A (en) * 1979-07-19 1980-12-09 Frazier Stephen E Antimicrobial compositions of matter and a process for preparing antimicrobial compositions of matter from naturally occurring flavanoid glycosides
US4297348A (en) * 1980-04-11 1981-10-27 Rush-Hampton Industries, Inc. Composition and method for the treatment of acne
HU194855B (en) * 1983-02-16 1988-03-28 Alkaloida Vegyeszeti Gyar Process for producing chromene derivatives, insecticide and nematocide compositions containing chromene derivatives as active components
GB8321943D0 (en) * 1983-08-15 1983-09-14 Erba Farmitalia Preparation of 2,3-dihydro-benzopyranone derivatives
WO1988008256A1 (en) * 1987-04-28 1988-11-03 University Patents, Inc. Dihydroflavonol derivatives useful as sweeteners
YU45458B (en) * 1987-10-05 1992-05-28 Vera Rozic Process for obtaining liquid ethanole extract of propolis
US4866080A (en) * 1988-01-13 1989-09-12 Buckman Laboratories International, Inc. Method for the control of mollusks
FR2633182B1 (fr) * 1988-06-23 1993-07-23 Beljanski Mirko Composition pharmaceutique anticancereuse et methode d'utilisation de l'invention
GB9201089D0 (en) * 1992-01-18 1992-03-11 Scient Generics Ltd A diagnostic article

Also Published As

Publication number Publication date
JP3682721B2 (ja) 2005-08-10
AU668348B2 (en) 1996-05-02
DK0707851T3 (da) 2002-04-22
ATE148341T1 (de) 1997-02-15
DE69232338D1 (de) 2002-02-14
US5449794A (en) 1995-09-12
AU1277992A (en) 1992-09-15
ES2100335T3 (es) 1997-06-16
DE69217206T2 (de) 1997-08-28
WO1992014458A1 (en) 1992-09-03
CA2104114A1 (en) 1992-08-16
CA2104114C (en) 2004-04-06
DK0571491T3 (da) 1997-08-11
DE69232338T2 (de) 2002-09-19
NZ241633A (en) 1994-06-27
EP0707851A2 (de) 1996-04-24
EP0571491B1 (de) 1997-01-29
EP0707851B1 (de) 2002-01-09
EP0707851A3 (de) 1998-04-01
JPH06508103A (ja) 1994-09-14
ES2171174T3 (es) 2002-09-01
DE69217206D1 (de) 1997-03-13
EP0571491A1 (de) 1993-12-01

Similar Documents

Publication Publication Date Title
ATE211651T1 (de) Benzopyranphenolderivate zur anwendung als bakterienhemmende, antivirale und wundheilende mittel
DE3851769D1 (de) Substituierte Benzazepine, ihre Herstellung und sie enthaltende Arzneimittel.
ES2177555T3 (es) Octaciclodepsipeptidos con actividad endoparasiticida.
ATE147725T1 (de) Biguanidederivate, verfahren zu ihrer herstellung und diese enthaltende desinfektionsmittel
DE3777544D1 (de) Glutaminsaeure-derivate, verfahren und zwischenprodukte zu ihrer herstellung und diese enthaltende pharmazeutische formulierungen.
ATE69807T1 (de) Phenoxyessigsaeure-verbindungen, ihre herstellung, pharmazeutische zusammensetzungen und deren verwendung.
IL109775A (en) Ascomycin derivatives their preparation and pharmaceutical compositions containing them
DE3678797D1 (de) Neue 3-oxadiazol- und 3-carbonsaeure-beta-carbolinderivate, ihre herstellung und ihre verwendung als arzneimittel.
DE69231815D1 (de) Verfahren zur Herstellung von Cephalosporinen und Zwischenprodukte in diesem Verfahren
PT80817A (en) Process for the preparation of carbamates,thiocarbamates and dithiocarbamates and their substituted derivatives containing aromatic radicals
ES8203906A1 (es) Procedimiento para la obtencion de cefalosporinas
DE69116237D1 (de) Derivate von Hexahydroazepine, Verfahren zu ihrer Herstellung und diese enthaltende Arzneimittel
ATE54448T1 (de) Cyclohexenonderivate, verfahren zur ihrer herstellung und ihre verwendung als herbizide mittel.
ATE173733T1 (de) Antimikrobielle carbapenem-derivate, ihre herstellung und ihre therapeutische verwendung
US4795832A (en) Salicylic acid amides, their use, and a process for their production
DE3672361D1 (de) Ein neues ansamycin-antibiotikum, ein mikrobielles verfahren zu seiner herstellung und seine verwendung als arzneimittel.
ATE100077T1 (de) 2-hydroxy-3-phenoxypropylaminoverbindungen.
ATE69448T1 (de) Chinolincarbonsaeure-derivate, diese enthaltende zusammensetzung, verfahren zu ihrer herstellung und ihre verwendung zur herstellung von medikamenten.
ATE151435T1 (de) Neue 17,20-epoxyd derivate von pregnan, ihre verwendung zur herstellung von cortison-derivaten und zwischenprodukte dafür
ZA903111B (en) 2-hydroxy-3-phenoxypropylamino compounds and pharmaceutical compositions containing them
NO895165L (no) Pyrazolopyridin-type mevalono-laktoner.
DE3882623D1 (de) Phosphorsaeurediester und salze davon.
ATE192141T1 (de) Aromatische hydroxamsäure-verbindungen, ihre herstellung und verwendung
ATE157959T1 (de) Indanderivate
DE69132107D1 (de) Substituierte beta-Diketone und deren Verwendung zur Behandlung von entzündlichen Eingeweidenerkrankungen

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee